T cell responses are correlated with recovery from and resistance to leishmaniasis. Antigens of Leishmania chagasi were evaluated by determining their ability to elicit in vitro proliferation and cytokine production in peripheral blood lymphocytes and in T cell lines and clones from patients with histories of leishmaniasis or Chagas' disease. Antigens tested were selected by their reactivity with patient antibodies. Several of the antigens induced proliferative responses in peripheral blood lymphocytes from patients recovered from visceral or cutaneous leishmaniasis or with chronic Chagas' disease. Two purified glycoproteins, 30 and 42 kD, were consistently among the most effective in eliciting high proliferative responses and IL-2 production. Lymphocytes from a recovered visceral leishmaniasis patient were used to produce T cell lines against either the 30-or 42-kD antigen. Each of the lines responded to both of these antigens as well as to crude leishmania lysate. Cb4+ T cell clones specific for either or both of these antigens were also isolated from a visceral leishmaniasis patient. In contrast, rabbit antisera produced against these two antigens were not crossreactive. Both antigens were effective in inducing the production of IFN-'y from T cell lines from both leishmaniasis and Chagas' disease patients. These studies demonstrate the potential for defining parasite antigens with broad immunostimulatory capabilities. (J. Clin. Invest. 1990. 85:690-696.) leishmania * antigens -T cells * leishmaniasis
Introduction
The leishmania are a complex of protozoan parasites that cause a spectrum of clinical diseases, including cutaneous, mucosal, and visceral leishmaniasis. They are obligate intracellular parasites of macrophages, which has important immunologic and therapeutic implications. T cell responses are of fundamental importance in leishmaniasis. In visceral leishmaniasis recovery is strongly correlated with a delayed-type hypersensitivity response to leishmania antigens (1) (2) (3) , as well as with proliferation of peripheral blood lymphocytes (4) . Patient's T cells also produce IFN-'y and IL-2 after recovery from acute disease (5) . This is of particular interest since IFN-y has Receivedfor publication 27 February 1989 and in revisedform 12 September 1989. been shown to inhibit the in vitro proliferation of leishmania in macrophages (6) . Based on these observations, it appears that evaluation of T cell responses to purified antigens is a logical way to identify molecules of leishmania with diagnostic and immunoprophylactic potential. In the present study we have identified and analyzed isolated antigens of Leishmania chagasi, the etiological agent of American visceral leishmaniasis. We have used these antigens to stimulate T cells from patients recovered from disease caused by L. chagasi or by the related parasites, L. braziliensis, L. amazonensis, and Trypanosoma cruzi. The parameters used for antigen evaluation were lymphocyte proliferation, IL-2 production by patient's peripheral blood lymphocytes, IFN--y production by T cell lines, and characterization of T cell clones stimulated by selected antigens.
Methods
Parasite antigen preparation. A clone of L. chagasi (MHOM/BR/82/ BA-2, Cl) was used in all studies (7) . Promastigotes were grown to stationary phase (2-3 X 107/ml) in RPMI 1640 (Gibco Laboratories, Grand Island, NY), supplemented with L-glutamine, Na pyruvate, MEM essential and nonessential amino acids (Gibco Laboratories), and 10% SeruMax (Sigma Chemical Co., St. Louis, MO). Crude antigen was prepared by sonicating promastigotes in 10 mM Tris, pH 7.5, 2 mM EDTA, 1.6 mM PMSF (Sigma Chemical Co.), and 100 Ig/ml leupeptin (Sigma Chemical Co.), followed by centrifugation (5,000 g, 20 min). Protein content of the supernatant was determined by the Pierce assay (Pierce Chemical Co., Rockford, IL). Preparative SDS-PAGE was performed by loading 3.2 mg total parasite protein onto a 1.5-mm-thick 12% polyacrylamide gel iii sample buffer (50 mM TrisHCl, 1% SDS, 10% glycerol, 2% 2-mercaptoethanol, 0.01% bromphenol blue) and running by standard procedure. A section of the gel was transferred to nitrocellulose for immunoblotting with patient serum for antigen band identification. Bands of interest were excised and gel slices were diced into 2-3-mm cubes and soaked overnight at 4VC in 2% SDS, 0.4 M NH4HCO3, and 0.1% dithiothreitol. The gel pieces and the soaking buffer were then placed into an electro-eluter (Bio-Rad Laboratories, Richmond, CA). Elution occurred for 6-7 h at 10 mA per tube in 0.05 M NH4HCO3, 0.1% SDS. The eluted fractions were dialyzed against 0.01 M NH4HCO3, 0.02% SDS for 24 h, followed by dialysis against a minimum of 100 vol of PBS, pH 7.4, for 3-5 d with two buffer changes per 24 h. All dialysis was done at 4VC. Eluted samples were assayed for protein content (Pierce assay) and checked for purity on SDS-PAGE mini-gels with silver staining (Bio-Rad Laboratories (8, 9). Clones were maintained by biweekly feedings with human recombinant IL-4 (100 ng/ml), and by stimulation every 10-14 d with irradiated (3,500 rad) autologous whole PBL and leishmania lysate (5 Mg/ml) with human recombinant IL-2 (10 ng/ml).
Proliferative assays and cytokine production. 
Results
PBL proliferative responses to parasite lysate or to partially purified antigens. Major antigenic bands of the SDS-PAGEseparated L. chagasi were identified using a serum pool from patients recovered from visceral leishmaniasis (Fig. 1) . Sera from normal individuals did not recognize leishmania antigens, as we have previously shown (7) . In initial studies, bands of Mr 116, 78, 72, 70, 65, 42, 40, 30, and 16 kD were chosen for use in in vitro proliferation assays. These bands were chosen based on their reactivity with sera from visceral leishmaniasis patients and with sera from Chagas' patients ( Fig. 1 blue-stained bands corresponding to the desired antigenic regions were excised and eluted from the gel and dialyzed to remove SDS. The purity of the fractions was ascertained on polyacrylamide gels before use in cell stimulation assays. All bands retained their antigenicity, as indicated by their ability to bind antibody from patients with cured visceral leishmaniasis on immunoblots (not shown). All proliferative assays were performed with antigens purified to a single SDS-PAGE band (Fig. 2) . The results from testing normal or patient cells for their ability to proliferate in response to crude homogenate or to representative partially purified leishmania antigens are shown in Table I . Several of the antigens were effective in stimulating PBL from visceral, mucosal, and cutaneous leishmaniasis patients, while none of the antigens tested stimulated significant proliferation in cells from normal individuals. Antigens of 30, 40, 42, and 70 kD were effective (> 10-fold proliferation above background) in stimulating significant proliferative responses in PBL cultures from leishmaniasis patients (Table I) . However, two bands, 30 and 42 kD, also elicited responses in cultures of PBL from Chagas' patients. These two bands were the only partially purified antigens tested that consistently elicited high responses from all three patient groups, and they were therefore chosen for further study. In subsequent analyses, other antigens were assayed for their ability to elicit proliferation in patient PBL, but none were consistently more effective than those represented in Table I .
Cytokine production by PBL and Tcell lines after exposure to leishmania antigens. The production of IL-2 by patient PBL (Table II) T cell lines generated from patients with cured visceral or cutaneous leishmaniasis or with chronic Chagas' disease were tested for their ability to produce IFN-'y in response to the 30-and 42-kD antigens. The results are shown in Table III . Cell lines from the two groups of leishmaniasis patients (visceral and cutaneous) produced significant levels of IFN-y in response to crude L. chagasi lysate, as we have previously reported for patient PBL (5). The production of IFN-'y was maximum at 72 h (data not shown). In addition, both the 30-and 42-kD antigens elicited significant IFN--y production by T cell lines from both patient groups. Of particular interest was the ability of these antigens, as well as crude lysate, to elicit IFN-y production in T cell lines from Chagas' patients.
T cell lines were also generated using purified 30-and 42-kD antigens by incubating PBL from a patient recovered from visceral leishmaniasis with gel-eluted protein. Lines were selected and restimulated using only the 30-or 42-kD antigens and tested after 30 d in culture for responsiveness to crude lysate or to partially purified antigens. The results are shown in Table IV . Both of the T cell lines responded to crude leishmania lysate. In addition, the T cell line generated against the 30-kD antigen responded to both the 30-and 42-kD antigens. The same was true for the line generated against the 42-kD antigen. This proliferation could not be explained by the survival of nonselected T cells from the PBL; cultures ofthe same PBL without added antigen (30-or 42-kD proteins) did not survive past day 10 of culture. These results suggest that T cell epitopes may be shared by the 30-and 42-kD antigens.
To further characterize T cells that responded to the 30-and 42-kD antigens, T cell clones that were specific for these antigens were identified. 148 T cell clones were generated from a patient recovered from acute visceral leishmaniasis. Several of these clones that responded to crude antigen with proliferation > 30-fold above background were also tested for proliferative responses to the 42-and 30-kD fractions. Of 39 clones tested for proliferation to the 30-kD antigen, 13 responded with a stimulation index of 10-fold or higher (Table V) . By the same criterion, 11 of 22 clones tested responded to the 42-kD L. chagasi antigen. The majority of the clones responded to both antigens, but two responded to the 30-and not the 42-kD antigen, while one responded to the 42-and not the 30-kD antigen. All of these clones were CD4+.
Partial characterization ofthe 42-and 30-kDfractions. Purity of the eluted fractions was obtained to the level of a single band on an SDS-PAGE gel (Fig. 2) . The antigens were treated with different proteolytic agents, including CnBr, trypsin, and endolys C. Both antigens were digested by each of these treatments (Figs. 3 and 4) , demonstrating their protein composition. In addition, each of the fractions bound all of the lectins used, as determined by incubation with biotinylated lectin followed by avidin-conjugated phosphatase. Binding of lentil lectin is illustrated in Fig. 5 . These results indicated that the 42-and 30-kD fractions appeared to be glycosylated.
Rabbit antisera raised against these two proteins demonstrated that they have unique antigen determinants. Sera from rabbits immunized with either antigen were immunoblotted on or used to immunoprecipitate leishmania lysates (Fig. 6, a  and b) . Each of the sera bound to the respective antigens, and neither bound to both antigens. This was true whether the sera were reacted with denatured (Fig. 6 a) or nondenatured (Fig. 6 b) leishmania lysate, illustrating that the 30-kD antigen is not likely to be a breakdown product of the 42-kD antigen. Fur- (4) . In addition to proliferative responses, we have shown a correlation between the ability of patient PBL to produce IL-2 and IFN-y in response to leishmania antigens after recovery from acute infection (5). We have therefore chosen proliferation and cytokine production to evaluate human lymphocyte responses to selected leishmania antigens. The approach used in this study to identify antigens of leishmania that may be important in stimulating leishmaniaspecific T cell activity was to elute them from gels and use them in soluble form for lymphocyte assays. This can have advantages over the Western blot approach ofantigen analysis, in which proteins transferred to nitrocellulose are used for in vitro lymphocyte assays. The use of antigens transferred to nitrocellulose makes it difficult to ensure either quantitatively or qualitatively that the same antigenic stimulus is consistently applied to each well. In contrast, when eluted soluble protein is used, it is possible to standardize a single lot of antigen for repeated testing.
Several antigens of L. chagasi stimulated PBL proliferative responses in the homologous patient group (persons with previous acute visceral leishmaniasis due to L. chagasi). Some of the antigens also elicited consistently high responses in PBL 1. Abbreviations used in this paper: gp, glycoprotein. from cutaneous or mucosal leishmaniasis and in PBL from Chagas' disease patients. Cross-reactivity between antigens of different Leishmania species and between antigens of leishmania and T cruzi occurs serologically (7, 12) , and also in the PBL proliferation assay (13) . Little has been done thus far to characterize the molecules that the parasites in these groups may have in common. Of the several proteins and glycoproteins shared by the leishmania that cause human disease, a 63-65-kD surface antigen appears to be highly conserved among these species and subspecies as judged by serological cross-reactivity (7, 14, 15) , and by DNA sequence analysis (our unpublished data). This antigen from L. chagasi appeared at 63-65 kD. This antigen is not recognized serologically by individuals with T. cruzi infections (7) . However, it is interesting to note that this antigen was among the most effective in stimulating T cells from both leishmaniasis and Chagas' patients. In Table I 24±11  32±0  23±12  T. cruzi lysate  0  ND  ND  ND  48±23  116  0  0  0  0  0  65  0  27±5  18±22  16±0  8±4  42  0  27±5  35±12  27±5  24±8  30  0  37±9  36±26  29±17  31±18 * Units of IL-2 were determined in cultures identical to those in this regard, purified gp 63 from L. major was suggested to have some effectiveness in the induction of protective T cell responses in mice (16) . Serological cross-reactivity was useful in selecting leishmania antigens for partial purification. Both gp 42 and gp 30 were identified initially on the basis oftheir reactivity with sera from patients with different forms of leishmaniasis and with sera from Chagas' disease patients. Although antigenic determinants recognized by B cells may differ from those recognized by T cells, as illustrated in studies on influenza virus (17, 18) , selection of a protein for studies of T cell responses was facilitated in this study by observations on antibody reactivity.
In the present study we have begun to characterize selected antigens of leishmania that are able to stimulate T cells from individuals with past leishmania infections or with chronic T. cruzi infections. At least two antigens, gp 30 and gp 42, elicited consistently high proliferative responses in all three patient groups to levels roughly equivalent to those obtained using crude leishmania extract. Many T cell clones generated from a patient with cured visceral leishmaniasis responded to both of these antigens, and T cell lines generated against each of the antigens responded to both antigens. These findings, together with the observation that both antigens were among the most effective in stimulating PBL proliferation and IL-2 production suggests that these antigens may have one or more common epitopes. That they may have unique epitopes as well was indicated by the finding of several T cell clones, isolated after subcloning, which respond to one but not both ofthe antigens, and by the production of non-cross-reactive rabbit antisera. Gp 30 and gp 42 may be major antigens for T cells, as indicated by the relatively high percentage of the clones analyzed that were specific for these antigens ( 13 of 39 tested and 11 of 22 tested, respectively). In addition, both gp 30 and gp 42 were effective in eliciting the production of IFN-'y from T cell lines from patients with either leishmaniasis or Chagas' disease. This may be an important consideration for selecting antigens as candidates for immunoprophylaxis because of the demonstrated importance of IFN-y in mediating intracellular destruction of leishmania (6) The possibility that the leishmania antigen-induced proliferation and cytokine production of PBL and T cell lines from Chagas' disease patients was due to multiple infections and not cross-reactivity is extremely slight. All of the Chagas' patients tested were from areas that are not endemic for leishmaniasis, and none had clinical histories, signs, or symptoms of any form of leishmaniasis. We have shown how the possibility of dual infection may' be ruled out in a previous report (3) .
In conclusion, we have begun to analyze antigens of leishmania that stimulate T lymphocyte responses in patients with treated leishmaniasis. The emphasis in this study was to characterize antigens that are capable of stimulating T cell responses from patients with infections caused by related parasites with the goal ofidentifying molecules having the potential to induce protective immune responses against more than one organism.
